Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions
NCT01532570
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Behcet's Disease
Behcet Syndrome
Neuro-Behcet's Disease
Interventions
DRUG:
TA-650
Sponsor
Tanabe Pharma Corporation